The reporter learned from the 2026 national health insurance catalogue on-site negotiation and commercial insurance innovative drug catalogue price negotiation site that the second day of the 2026 national talks began at around 8 o'clock, and representatives of nearly 20 domestic and foreign pharmaceutical companies, including Heyuan Biotech, Yuanda Pharmaceutical, Hengrui Pharmaceuticals, Qilu Pharmaceuticals, Lilai, China Biopharmaceutical's Chia Da Tianqing, Shiyao Group, Sanofi, Cinda Biotech, and Novartis entered the negotiations one after another. Among them, Heyuan Biotech's CAR-T drug Naciorense injection entered the commercial insurance innovative drug list last year. This year, the national negotiations applied for entry into the basic medical insurance catalogue and passed the preliminary review, and also applied for adjustment of the indications in the commercial insurance catalogue. It is estimated that the types of drugs negotiated in the morning include cancer treatment drugs.

Zhitongcaijing · 2d ago
The reporter learned from the 2026 national health insurance catalogue on-site negotiation and commercial insurance innovative drug catalogue price negotiation site that the second day of the 2026 national talks began at around 8 o'clock, and representatives of nearly 20 domestic and foreign pharmaceutical companies, including Heyuan Biotech, Yuanda Pharmaceutical, Hengrui Pharmaceuticals, Qilu Pharmaceuticals, Lilai, China Biopharmaceutical's Chia Da Tianqing, Shiyao Group, Sanofi, Cinda Biotech, and Novartis entered the negotiations one after another. Among them, Heyuan Biotech's CAR-T drug Naciorense injection entered the commercial insurance innovative drug list last year. This year, the national negotiations applied for entry into the basic medical insurance catalogue and passed the preliminary review, and also applied for adjustment of the indications in the commercial insurance catalogue. It is estimated that the types of drugs negotiated in the morning include cancer treatment drugs.